TITLE

Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: Systematic review and metaanalysis

AUTHOR(S)
Osborn, David PJ; Wright, Christine A; Levy, Gus; King, Michael B; Deo, Raman; Nazareth, Irwin
PUB. DATE
January 2008
SOURCE
BMC Psychiatry;2008, Vol. 8, Special section p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Severe mental illnesses (SMI) may be independently associated with cardiovascular risk factors and the metabolic syndrome. We aimed to systematically assess studies that compared diabetes, dyslipidaemia, hypertension and metabolic syndrome in people with and without SMI. Methods: We systematically searched MEDLINE, EMBASE, CINAHL & PsycINFO. We hand searched reference lists of key articles. We employed three search main themes: SMI, cardiovascular disease, and each cardiovascular risk factor. We selected cross-sectional, case control, cohort or intervention studies comparing one or more risk factor in both SMI and a reference group. We excluded studies without any reference group. We extracted data on: study design, cardiovascular risk factor(s) and their measurement, diagnosis of SMI, study setting, sampling method, nature of comparison group and data on key risk factors. Results: Of 14592 citations, 134 papers met criteria and 36 were finally included. 26 reported on diabetes, 12 hypertension, 11 dyslipidaemia, and 4 metabolic syndrome. Most studies were cross sectional, small and several lacked comparison data suitable for extraction. Meta-analysis was possible for diabetes, cholesterol and hypertension; revealing a pooled risk ratio of 1.70 (1.21 to 2.37) for diabetes and 1.11 (0.91 to 1.35) of hypertension. Restricting SMI to schizophreniform illnesses yielded a pooled risk ratio for diabetes of 1.87 (1.68 to 2.09). Total cholesterol was not higher in people with SMI (Standardized Mean Difference -0.10 (-0.55 to 0.36)) and there were inconsistent data on HDL, LDL and triglycerides with some, but not all, reporting lower levels of HDL cholesterol and raised triglyceride levels. Metabolic syndrome appeared more common in SMI. Conclusion: Diabetes (but not hypertension) is more common in SMI. Data on other risk factors were limited by poor quality or inconsistent research findings, but a small number of studies show greater prevalence of the metabolic syndrome in SMI.
ACCESSION #
35702844

 

Related Articles

  • Cardiometabolic Disorders.  // Pharmaceutical Representative;Nov2009, Vol. 39 Issue 11, p21 

    The article presents Part II of the report on cardiometabolic disorders which examines the risks and links between obesity, diabetes, hypertension, and lipid disorders. It explores the prevalence of interrelated symptoms that affect one quarter of Americans with elevated triglycerides or blood...

  • Cardiometabolic syndrome: How to achieve patient buy-in. HERTZ, BETH THOMAS // Medical Economics;11/10/2013, Vol. 90 Issue 21, p58 

    The article presents information on the treatment of cardiometabolic syndrome. High blood pressure, poor control of diabetes, lipid disorders, excess body fat around the waist, high cholesterol levels, sounds similar to a normal day of diagnoses and observations for several primary care...

  • Metabolic Syndrome in People Suffering from Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis. Bartoli, Francesco; Carrà, Giuseppe; Crocamo, Cristina; Carretta, Daniele; Clerici, Massimo // Metabolic Syndrome & Related Disorders;Oct2013, Vol. 11 Issue 5, p301 

    Background: Previous reports showed a high prevalence of obesity, diabetes, hypertension, and dyslipidemia among people suffering from posttraumatic stress disorder (PTSD). However, there is a lack of reviews that systematically analyze the relationship between PTSD and metabolic syndrome. We...

  • Metabolic Syndrome Risk after Gestational Diabetes: A Systematic Review and Meta-Analysis. Xu, Yuhong; Shen, Shutong; Sun, Lizhou; Yang, Haiwei; Jin, Bai; Cao, Xiaohui // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: A number of studies have been conducted to investigate the risk of metabolic syndrome (MS) after gestational diabetes mellitus (GDM), but the results are contradictory. Accordingly, we performed a systematic review and meta-analysis to assess the association between these two...

  • Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Moran, Lisa J.; Misso, Marie L.; Wild, Robert A.; Norman, Robert J. // Human Reproduction Update;Jan2011, Vol. 17 Issue 1, p138 

    No abstract available.

  • Metabolic syndrome and endometrial cancer: a meta-analysis. Esposito, Katherine; Chiodini, Paolo; Capuano, Annalisa; Bellastella, Giuseppe; Maiorino, Maria; Giugliano, Dario // Endocrine (1355008X);Feb2014, Vol. 45 Issue 1, p28 

    We performed a systematic review and meta-analysis on the association of metabolic syndrome with endometrial cancer. A systematic literature search of electronic databases (Medline, ISI Web of Knowledge and Scopus) was conducted and complemented by cross-referencing to identify studies published...

  • Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis. Esposito, Katherine; Chiodini, Paolo; Capuano, Annalisa; Bellastella, Giuseppe; Maiorino, Maria Ida; Rafaniello, Concetta; Panagiotakos, Demosthenes B.; Giugliano, Dario // Endocrine (1355008X);Dec2013, Vol. 44 Issue 3, p634 

    We performed a systematic review and meta-analysis of the empirical evidence on the association of metabolic syndrome and its components with colorectal cancer incidence and mortality. A systematic literature search of multiple electronic databases was conducted and complemented by...

  • Metabolically Healthy Overweight and Obesity. Lesser, Gerson T. // Annals of Internal Medicine;4/1/2014, Vol. 160 Issue 7, p514 

    Two letters to the editor are presented in response to two articles related to a meta-analysis and systematic review of metabolic health in obesity in the 2013 issue including one by C.K. Kramer and colleagues and another by J.O. Hill and colleagues.

  • Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis. Medic, Goran; Higashi, Kyoko; Littlewood, Kavi J.; Diez, Teresa; Granström, Ola; Kahn, René S. // Neuropsychiatric Disease & Treatment;2013, Vol. 9, p119 

    Background: The purpose of this study was to investigate the impact of dosing frequency on adherence in severe chronic psychiatric and neurological diseases. Methods: A systematic literature review was conducted for articles in English from medical databases. Diseases were schizophrenia,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics